Kyntra Bio Inc. share price logo

Kyntra Bio Inc.

NASDAQ: KYNB

$7.23

-0.16

(-2.17%)

as on

Kyntra Bio Inc. Stock Performance

as on July 18, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.16
    $7.39
    downward going graph

    0.97%

    Downside

    2.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Kyntra Bio Inc. share price movements today

Previous Close
$7.39
Open
$7.38
Volume
313.2K
Day's Low - High
$7.16 - $7.39

Kyntra Bio Inc. Historical Returns

1 Month Return
+ 7.91 %
3 Month Return
-1.23 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Kyntra Bio Inc. Stock Fundamentals & Key Indicators

Check Kyntra Bio Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$29.9M

EPS (TTM)

-13.75

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Kyntra Bio Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kyntra Bio Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Kyntra Bio Inc. image
Kyntra Bio Inc.
NA$29.9MNANA2199.42%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$38.1B524.49%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$123.4B140.09%28.3235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$71.2B16.02%16.2329.65%0.54%

Indian Investors' Interest in Kyntra Bio Inc. Stock

Search interest for Kyntra Bio Inc. Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-18% versus previous 30 day period

Kyntra Bio Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
27
25
0
46
-123
2
1
1
1
3
Gross Profit
21
-32
-31
41
-102
2
1
0
1
0
Operating Income
-54
-49
-46
-16
-91
-14
-11
-5
-14
-13
EBITDA
-49
-46
-44
-12
-91
-14
-11
-10
-20
-12
Interest Expense
5
2
1
4
2
2
2
2
2
2
Depreciation
-
-
-
0
0
0
0
0
0
0
Income Before Tax
-56
-49
-47
-17
-87
-16
-13
-13
-14
-15
Income Tax Expense
0
0
0
0
0
0
0
-
0
0
Net Income
-56
-32
-15
-17
17
4
-7
148
37
-15
Net Profit Margin
-207.21%
-129.84%
-1557.52%
-36.87%
-14.59%
169.37%
-564.02%
13798.61%
2971.26%
-406.58%

Kyntra Bio Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
179
125
212
256
176
235
140
46
29
6
Gross Profit
-7
-70
-22
255
167
-213
120
42
14
5
Operating Income
-53
-122
-86
-89
-191
-288
-301
-322
-150
-45
EBITDA
-44
-104
-68
-52
-164
-333
-282
-305
-142
-57
Interest Expense
10
9
10
2
2
1
1
8
8
8
Depreciation
-
-
-
-
-
14
10
9
2
0
Income Before Tax
-61
-125
-86
-76
-188
-289
-293
-323
-153
-58
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-61
-126
-86
-76
-189
-290
-293
-284
-47
183
Net Profit Margin
-34.35%
-100.43%
-40.58%
-30.00%
-107.36%
-123.25%
-208.66%
-607.29%
-160.63%
2848.63%

Kyntra Bio Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-32
-15
-17
17
4
-7
200
-14
-15
Operating Cash Flow
-59
-39
-8
-30
2
12
-1
-18
-13
Investing Cash Flow
51
72
0
1
0
0
87
-51
3
Financing Cash Flow
0
0
0
0
0
0
-85
0
0
Change in Cash
-7
34
-9
-28
4
13
-1
-70
-10

Kyntra Bio Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-120
-86
-76
-189
-290
-293
-284
-47
183
Operating Cash Flow
-66
-76
-78
81
-82
-145
-315
-137
-4
Investing Cash Flow
69
-522
120
452
-426
89
153
125
35
Financing Cash Flow
496
13
-4
13
0
46
122
0
-86
Change in Cash
499
-584
37
552
-507
-15
-42
-11
-54

Global Institutional Holdings in Kyntra Bio Inc.

Funds
Holdings
Birchview Capital, LP
0.56%
Group One Trading, LP
0.11%
Vanguard Global Advisers, LLC
0.04%
Axiom Investment Management LLC
0.02%
Vanguard Group Inc
4.5%
See all

Insights on Kyntra Bio Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.07M → 3.73M (in $), with an average increase of 40.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 386.1% return, outperforming this stock by 391.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 593.9% return, outperforming this stock by 682.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 148.47M → -15.19M (in $), with an average decrease of 107.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, KYNB stock has moved down by -88.7%

About Kyntra Bio Inc.

Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers. It is also developing Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was formerly known as FibroGen, Inc. and change its name to Kyntra Bio, Inc. in January 2026. Kyntra Bio, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
OrganisationKyntra Bio Inc.
Headquarters350 Bay Street, San Francisco, CA, United States, 94133
IndustryBiotechnology
CEOMr. Thane Wettig
E-voting on sharesClick here to vote

Key Management of Kyntra Bio Inc.

Name

Title

Mr. Thane Wettig

CEO & Director

Mr. David DeLucia

Senior VP & CFO

Mr. John Alden

Corporate Secretary & General Counsel

Ms. Michelle Simonetti

Head of People and Culture & Executive Director

Ms. Gaia Vasiliver-Shamis

Director of IR & Communications - LifeSci Advisors

FAQs

What is Kyntra Bio Inc. share price today?

Kyntra Bio Inc. share price today is $7.23 as on at the close of the market. Kyntra Bio Inc. share today touched a day high of $7.39 and a low of $7.16.

What is the 52 week high and 52 week low for Kyntra Bio Inc. share?

Kyntra Bio Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Kyntra Bio Inc. stock price today i.e. is closed at $7.23,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kyntra Bio Inc.'s market capitalisation today?

Kyntra Bio Inc. market capitalisation is $0.00T as on .

How to invest in Kyntra Bio Inc. Stock (KYNB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kyntra Bio Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kyntra Bio Inc. Shares that will get you 0.2075 shares as per Kyntra Bio Inc. share price of $7.23 per share as on July 18, 2026 at 8:45 am IST.

What is the minimum amount required to buy Kyntra Bio Inc. Stock (KYNB) from India?

Indian investors can start investing in Kyntra Bio Inc. (KYNB) shares with as little as ₹96.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.80 in Kyntra Bio Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Kyntra Bio Inc. share’s latest price of $7.23 as on July 18, 2026 at 8:45 am IST, you will get 1.3831 shares of Kyntra Bio Inc.. Learn more about fractional shares .